ID: MRFR/HC/8540-HCR | February 2021 | Region: Global | 100 pages
Global Veterinary POC Diagnostic Market is expected to hold a value of USD 2,894 Million by 2027 and is expected to register a growth of 8.9% from 2020 to 2027.
Medical discoveries have made tremendous changes in the veterinary healthcare system like Point-of-Care (PoC), it enables rapid results in non-laboratory settings. There is traction in the veterinary point-of-care diagnostics market due to the adoption of advanced and innovative diagnostic testing methods. Increased prevalence of various pandemic diseases such as swine flu, rabies. Less period in testing and results, precise results, change in diagnostic trend, and adoption of state-of-art technologies are anticipated to foster the PoC .
Veterinary diagnostic products are as complex as they are difficult to manufacture. Many of the poultry and livestock diagnostic products are biologic products that demand materials from living organisms. Market development for companion animal diagnostic has depended heavily upon the purchasing and usage of in-clinic analyzers or diagnostic instruments used at veterinary practices.
By Animal Types
|Market Size||2027: USD 2,894 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product, Technology, Application, Animal Type and End User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Thermo Fisher Scientific, Inc. (US), Idexx Laboratories, Inc. (US), Zoetis, Inc. (US), Virbac (France), Heska Corporation (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company Ltd. (UK), Randox Laboratories, Ltd. (UK), AniPoC, Ltd. (UK), Carestream Health, Inc. (US), Neurologica Corporation (US), Fujifilm Sonosite, Inc. (Japan), Diagnostic Imaging Systems, Inc. (US), Esaote spa (Italy), Mindray Medical International Limited (A Part of Excelsior Union Limited) (China), GE Healthcare (US), Minxray, Inc. (US), QR s.r.l. (Italy), Sedecal (Spain), Examion GmbH (Germany).|
|Key Market Opportunities||
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
Global Veterinary POC Diagnostic Market is projected to hold a value of USD 2,894 million by the end of 2027.
Global Veterinary POC Diagnostic Market is predicted to expand at a CAGR of 8.9% by the end of 2027.
Global Veterinary POC Diagnostic Market is estimated to be driven by the increasing demand for pet insurance and growing expenses on animal health expenditure.
Global Veterinary POC Diagnostic Market is projected to be constrained by the expensive cost of veterinary imaging instruments and growing pet care costs.
Thermo Fisher Scientific, Inc. (the US), Idexx Laboratories, Inc. (the US), Zoetis, Inc. (the US), Virbac (France), GE Healthcare (US), Minxray, Inc. (the US), QR s.r.l. (Italy), Sedecal (Spain), and Examion GmbH (Germany) are some of the most renowned players of the global veterinary POC Diagnostic market.
This table of content is tentative and subject to change as the research progresses.
Please Note: Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.